Latest Period
Q4 2025
Security Snapshot
ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) Institutional Ownership
CUSIP: 74346M505
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
9
Shares (Excl. Options)
264,549
Price
$6.82
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Shares, no par value per share
- Symbol
- PMN on Nasdaq
- Shares outstanding
- 4,100,581
- Price per share
- $12.92
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 264,549
- Total reported value
- $1,798,689
- % of total 13F portfolios
- 0%
- Share change
- +264,549
- Value change
- +$1,798,689
- Number of holders
- 9
- Price from insider filings
- $12.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PMN - ProMIS Neurosciences Inc. - Common Shares, no par value per share is tracked under CUSIP 74346M505.
- 9 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 9 to 1 between Q4 2025 and Q1 2026.
- Reported value moved from $1,798,689 to $16,510.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 9 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP 74346M505?
CUSIP 74346M505 identifies PMN - ProMIS Neurosciences Inc. - Common Shares, no par value per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74346M505:
Significant Owners of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ABG Management Ltd. | 17% | $725,179 | 1,644,397 | Fan Yu | 03 Feb 2026 | |||
| Trails Edge Capital Partners, LP | 9.9% | $6,347,644 | 933,477 | Trails Edge Capital Partners, LP | 03 Feb 2026 | |||
| Deep Track Capital, LP | 10% | $6,137,415 | 902,561 | Deep Track Capital, LP | 30 Jan 2026 | |||
| GREAT POINT PARTNERS LLC | 10% | $2,790,563 | 409,648 | Great Point Partners, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 9 institutional investors reported holding 264,549 shares of ProMIS Neurosciences Inc. - Common Shares, no par value per share (PMN). This represents 6.5% of the company’s total 4,100,581 outstanding shares.